EUVIMEDEUVIMED entdecken
Crossref

High‐risk human papillomavirus 16/18 associated with improved survival in sinonasal squamous cell carcinoma

Shreya P Ramkumar, Matthew C Simpson, Eric Adjei Boakye, Aleksandr R Bukatko, Jastin L Antisdel, Sean T Massa iD, Nosayaba Osazuwa-Peters iD

Cancer · 2023

DOI: 10.1002/cncr.34690 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, 2023. Verfasst von Shreya P Ramkumar und 6 weiteren Autor:innen. Beteiligte Einrichtung: St Louis University School of Medicine, St Louis, Missouri, USA. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Paranasal Sinus Neoplasms, Papillomavirus Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: NIDCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There has been conflicting evidence on the independent prognostic role of human papillomavirus (HPV) status in sinonasal cancer. The objective of this study was to assess whether the survival of patients with sinonasal cancer differs based on various HPV statuses, including HPV‐negative, positive for the high‐risk HPV‐16 and HPV‐18 (HPV16/18) subtypes, and positive for other high‐risk and low‐risk HPV subtypes.

Methods

In this retrospective cohort study, data from the National Cancer Database were extracted from the years 2010–2017 for patients who had primary sinonasal cancer ( N = 12,009). The outcome of interest was overall survival based on HPV tumor status.

Results

Study included an analytic cohort of 1070 patients with sinonasal cancer who had confirmed HPV tumor status (732 [68.4%] HPV‐negative; 280 [26.2%] HPV16/18‐positive; 40 [3.7%] positive for other high‐risk HPV; and 18 [1.7%] positive for low‐risk HPV). HPV‐negative patients had the lowest all‐cause survival probability at 5 years postdiagnosis (0.50). After controlling for covariates, HPV16/18‐positive patients had a 37% lower mortality hazard than HPV‐negative patients (adjusted hazard ratio, 0.63; 95% confidence interval [CI], 0.48–0.82). Patients aged 64–72 years (crude prevalence ratio, 0.66; 95% CI, 0.51–0.86) and 73 years and older (crude prevalence ratio, 0.43; 95% CI, 0.31–0.59) presented with lower rates of HPV16/18‐positive sinonasal cancer than those aged 40–54 years. In addition, Hispanic patients had a 2.36 times higher prevalence of non‐HPV16/18 sinonasal cancer than non‐Hispanic White patients.

Conclusions

These data suggest that, for patients with sinonasal cancer, HPV16/18‐positive disease may confer a significant survival advantage compared with HPV‐negative disease. Other high‐risk and low‐risk HPV subtypes have survival rates similar to the rates for HPV‐negative disease. HPV status might be an important independent prognostic factor in sinonasal cancer that could be used in patient selection and clinical decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellParanasal Sinus NeoplasmsPapillomavirus InfectionsHumansHuman Papillomavirus VirusesRetrospective StudiesHuman papillomavirus 16Squamous Cell Carcinoma of Head and Neck

Stichwörter der Autor:innen

National Cancer Database (NCDB)cancer survivalhigh-risk human papillomavirushuman papillomavirus (HPV)human papillomavirus 16/18sinonasal cancer

Autor:innen und Institutionen

  • St Louis University School of Medicine, St Louis, Missouri, USA.
  • Department of Otolaryngology Head and Neck Surgery, St Louis University School of Medicine, St Louis, Missouri, USA.
  • Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA.
  • Department of Otolaryngology Head and Neck Surgery, Henry Ford Health System, Detroit, Michigan, USA.
  • Santa Rosa Community Health, Santa Rosa, California, USA.
  • Department of Head and Neck Surgery & Communication Sciences, Duke University School of Medicine, Durham, North Carolina, USA.

ORCID-Profile: Sean T Massa, Nosayaba Osazuwa-Peters

Förderung

  • NIDCR NIH HHS

Zitieren

APA

Ramkumar, S. P., Simpson, M. C., Adjei Boakye, E., Bukatko, A. R., Antisdel, J. L., Massa, S. T., & Osazuwa-Peters, N. (2023). High‐risk human papillomavirus 16/18 associated with improved survival in sinonasal squamous cell carcinoma. Cancer. https://doi.org/10.1002/cncr.34690

Vancouver

Ramkumar SP, Simpson MC, Adjei Boakye E, Bukatko AR, Antisdel JL, Massa ST, et al. High‐risk human papillomavirus 16/18 associated with improved survival in sinonasal squamous cell carcinoma. Cancer. 2023. doi:10.1002/cncr.34690

BibTeX
@article{Ramkumar2023,
  author = {Ramkumar, Shreya P and Simpson, Matthew C and Adjei Boakye, Eric and Bukatko, Aleksandr R and Antisdel, Jastin L and Massa, Sean T and Osazuwa-Peters, Nosayaba},
  title = {High‐risk human papillomavirus 16/18 associated with improved survival in sinonasal squamous cell carcinoma},
  journal = {Cancer},
  year = {2023},
  doi = {10.1002/cncr.34690}
}
Kostenlos starten →